Cytokinetics, Incorporated
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersSouth San Francisco, CA
US patents256
SAM.gov UEIJT8GF38LKDF4
CAGE code9DCX5
Incorporated inDE
LEI549300BE5DY1HW7IHA64
Open positions
Openings read from Cytokinetics, Incorporated’s own job board on Workday, last checked OCT 27, 2026. FactoryRegistry does not host applications — each title opens the posting where the company published it.
- Key Account Manager, Cardiovascular (Munich, Germany)Remote - Germany · posted OCT 27, 2026
- Senior Quality Assurance Specialist - Drug ProductIreland · posted OCT 27, 2026
- Senior Patent AgentCytokinetics, Incorporated · South San Francisco, California · posted OCT 27, 2026
- Cardiovascular Account Specialist - U.S. Sales, Pasadena, CARemote; LOS ANGELES, CA · posted OCT 24, 2026
- Senior ScientistCytokinetics, Incorporated · South San Francisco, California · posted OCT 23, 2026
- Associate Director, Business Insights & Analytics Data ScientistRadnor, Pennsylvania · posted OCT 23, 2026
- Senior Manager, CMC Analytical ChemistryCytokinetics, Incorporated · South San Francisco, California · posted OCT 23, 2026
- Senior Manager, IT Technical SecurityCytokinetics, Incorporated · South San Francisco, California · posted OCT 23, 2026
- Associate Director, Business Insights & AnalyticsRadnor, Pennsylvania · posted OCT 23, 2026
- Cardiovascular Account Specialist - U.S. Sales, San Antonio, TXRemote · posted OCT 23, 2026
72 more on the company’s board
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
256 US patents granted 1996–2025, 36 of them in the five years to SEP 2025.
Organic fine chemistry 80Pharmaceuticals 79Biotechnology 56Measurement 31Computer technology 10
- Methods for treating hypertrophic cardiomyopathyUS 12,370,179 · granted JUL 29, 2025
- Methods of treating heart failure with cardiac sarcomere activatorsUS 12,295,952 · granted MAY 13, 2025
- Cardiac sarcomere inhibitorsUS 12,286,437 · granted APR 29, 2025
- Cardiac sarcomere inhibitorsUS 12,275,741 · granted APR 15, 2025
- Heterocyclic compounds and their usesUS 12,275,704 · granted APR 15, 2025
Newest 5 shown · Granted to Cytokinetics, INC. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Cytokinetics, Incorporated | South San Francisco | CA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.


